PTV Healthcare Capital

PTV Healthcare Capital primarily invests in mid-to-late-stage healthcare companies, focusing on sectors such as medical devices, diagnostics, biotechnology, and healthcare IT. The firm seeks to partner with entrepreneurs who are dedicated to improving healthcare outcomes and reducing costs, aligning with broader healthcare reform initiatives. PTV Healthcare Capital typically engages in Series A, Series B, Series C, and growth equity rounds, although specific check sizes are not disclosed.

The firm emphasizes collaboration and integrity in its investment approach, aiming to provide not only capital but also operational expertise, regulatory guidance, and business expansion resources to its portfolio companies. PTV Healthcare Capital looks for companies that have already mitigated some of their commercial, regulatory, and technical risks, which enhances their potential for success in the healthcare market.

While the firm has a clear focus on healthcare innovation, the lack of current information regarding their investment thesis and specific check sizes limits the ability to provide a comprehensive overview of their investment strategy. Founders should consider reaching out through verified channels to confirm current operations and investment criteria.

PTV Healthcare Capital has invested in several notable companies within the healthcare sector. Key portfolio companies include:

• Cardiva Medical: A vascular closure device company acquired by Haemonetics in January 2021.
• Intuity Medical: A diabetes management firm known for its blood glucose monitoring solutions.
• Cameron Health: A company focused on developing next-generation implantable electronic devices.
• Accumetrics: Specializes in diagnostics instrumentation and test kits, including VerifyNow platelet-function assessment.
• Apollo Endosurgery: Develops minimally invasive surgical devices.
• Asuragen: Focuses on molecular diagnostics and oncology diagnostics.
• BioForm Medical: Provides medical aesthetics and dermatology products.
• GlycoMimetics: A biotechnology company developing carbohydrate-mimetic small molecules for inflammatory diseases and cancer.
• IDEV Technologies: Engages in interventional radiology and vascular surgery medical devices.
• Intersect ENT: Develops medical devices for chronic sinusitis therapy.
• LDR Spine: Focuses on orthopedic and spinal implant devices.
• Ortho Kinematics: Specializes in spine diagnostics.
• Tryton Medical: Develops coronary bifurcation stents.
• ZIOPHARM Oncology: A biopharmaceutical company focused on oncology.

These investments reflect PTV Healthcare Capital's commitment to supporting companies that are innovating within the healthcare sector, particularly those that have demonstrated potential for significant impact on patient outcomes and cost reduction.

Matthew S. Crawford: Founding Managing Director. He founded PTV Healthcare Capital in 2003 and has extensive experience in healthcare investing. His background includes leadership roles in various healthcare ventures.

Rick Anderson: Managing Director. He has been involved in the firm since its inception and plays a key role in investment decisions and portfolio management.

Marsha Garcia: Director of Operations. She oversees operational aspects of the firm and is involved in investor relations and compliance.

Lauren Chauret: Director of Operations and Chief Compliance Officer. She manages investor relations, finance, accounting, and compliance, supporting investment structuring.

Clay Samford: Financial Analyst. He has contributed to investment analysis and portfolio management, focusing on healthcare companies.

Robert Kean Hatcher: Advisory Manager. He provides strategic insights and guidance to the firm and its portfolio companies.

To pitch PTV Healthcare Capital, founders should reach out via email at alexa@ptvhc.com. While specific guidelines for pitch decks are not provided, it is advisable to include comprehensive information about the startup's business model, market potential, and how it aligns with PTV's investment focus on healthcare innovation.

Due to the current status of the firm's website, which is under construction, founders may not find a formal application process or submission portal. A warm introduction through industry connections may enhance the chances of a successful pitch.

Response times are not disclosed, so founders should be prepared for potential delays in communication. It is crucial to verify the current operational status of PTV Healthcare Capital before reaching out, as the firm appears to be in a legacy state.

As of May 2026, there have been no recent public announcements or activities from PTV Healthcare Capital. The firm is currently facing challenges with its online presence, as its official website is under construction and does not provide updates on recent investments or operational activities.

Historically, PTV Healthcare Capital was involved in significant deals, including the Series H round for Cardiva Medical in July 2020, which raised $45 million. Cardiva Medical was subsequently acquired by Haemonetics in January 2021, marking a notable exit for the firm.

While the firm has a legacy of supporting healthcare innovation, the lack of current activity signals a need for caution when considering outreach for new investments.